Skip to main content
Funding round pulls in $5M for One BioMed

A round of Series A funding has pulled in $5 million for Singapore-based diagnostics company One BioMed, which intends to use the proceeds to fund commercialization of its automated sample preparation diagnostic platform for nucleic acid purification and isolation.

Full Story: